Skip to content
Sign up to receive our free weekday morning edition, and you'll never miss a scoop.
Cornyn trails Paxton by just five points in a new poll of the Senate race from TSU — an indication he may be winnowing down a huge polling gap.

Cornyn shows signs of closing polling gap

Sen. John Cornyn (R-Texas) trails Texas Attorney General Ken Paxton by just five points in a new poll of the Senate race from Texas Southern University — an indication he may be winnowing down a huge polling gap.

Paxton led Cornyn 44% to 39% in a survey of 1,500 likely GOP primary voters conducted Aug. 6-12. Another 17% were unsure. The poll was conducted via SMS by TSU’s Barbara Jordan Policy Research and Survey Center.

This is a significant improvement for Cornyn, who has trailed by much larger margins for much of the year in public and private polling. The senator’s allies have been spending millions on TV over the summer to boost his numbers. And this survey could be a sign that effort is working.

It’s not the only recent poll that has brought good news for Cornyn. The senator led Paxton by 1 point, 30% to 29% with 37% undecided in a mid-August survey from Emerson College. But that poll had a small sample size of 491 GOP voters.

A couple other notable results from the TSU survey: Rep. Wesley Hunt (R-Texas), who is considering a Senate run, pulled 22% in a three-way of the race. Cornyn got 30% and Paxton 35% in that scenario.

Cornyn’s allies make the point that the pair of surveys are the first since news broke about Paxton’s divorce. Paxton led by an average of 17 points in more than a dozen polls dating back a few months. Several entities are in the field this month with new polls.

TSU also tested the Democratic primary for the Senate race. Former Rep. Beto O’Rourke (D-Texas), who isn’t a declared candidate, led former Rep. Colin Allred (D-Texas), who is in the race, 58% to 38%. Allred led Texas state Rep. James Talarico, who has been inching toward a run, 50% to 43%.

Presented by AstraZeneca

The 340B program was created to help patients. Instead, it’s helping hospitals earn massive profits. The 340B Rebate Model Pilot uses rapid verification of existing data to prevent duplicate discounts, strengthening program transparency and efficiency. Urge HHS to implement the Rebate Model Pilot and ensure 340B functions as intended. Get the facts.

Editorial photos provided by Getty Images. Political ads courtesy of AdImpact.

Presented by AstraZeneca

The 340B program is supposed to help vulnerable patients—but without strong safeguards, it’s siphoning away funds that could be used for free and charitable medicine. The 340B Rebate Model Pilot improves program integrity, preventing duplicate discounts and strengthening accountability. Urge HHS to implement the pilot today. Learn why it matters.

Welcome to Punchbowl News AM! We're glad to have you here.

Want to get more of what you need? Share a bit more about yourself to help us tailor your reader experience.

Thank you for signing up!

Thank you for signing up!

 

We have sent you a confirmation email. Please follow the provided instructions to complete your sign-up.

Thank you for confirming! You are now subscribed to the Punchbowl News AM list.

You're subscribed! Welcome to the community.